CLASS II ONGOING Device recall · Reported 27 Nov 2024 · FDA Enforcement Report

Bard Marquee Disposable Core Biopsy Instrument Kit: Bard Marquee Kit recalled

Bard Peripheral Vascular is recalling Bard Marquee Disposable Core Biopsy Instrument Kit: Bard Marquee Kit, distributed nationwide in the US. The recall was initiated on 30 Sep 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF/UDI-DI/Lot(Expiration): MQK1210/00801741097263/1490758(9/28/2025), 1506044(1/28/2026), 1506045(1/28/2026), 1511827(2/28/2026), 1514692(3/28/2026), 1518977(4/28/2026), 1518978(4/28/2026), 1518979(4/28/2026), 1519143(4/28/2026), 1520507(5/28/2026), 1520508(5/28/2026), 1522157(5/28/2026), 1522158(5/28/2026), 1522577(5/28/2026), 1523785(6/28/2026), 1523914(6/28/2026), 1523915(6/28/2026), 1525370(6/28/2026), 1525371(6/28/2026), 1525373(6/28/2026), 1528417(7/28/2026), 1528418(7/28/2026), 1528495(7/28/2026), 1528496(7/28/2026), 1528497(7/28/2026), 1528560(7/28/2026), 0001618867(3/28/2028), 0001620281(3/28/2028), 0001632675(6/28/2028); MQ1210/00801741097119/1514460(3/28/2026), 1514461(3/28/2026), 1519144(4/28/2026), 1519145(4/28/2026), 1519456(4/28/2026), 1520066(5/28/2026), 1520067(5/28/2026), 1520506(5/28/2026), 1523783(6/28/2026), 1523784(6/28/2026), 0001618258(3/28/2028), 0001631611(6/28/2028), 0001633216(7/28/2028); MQK1213/00801741097270/1543517(10/28/2026), 1559312(2/28/2027), 1562724(3/28/2027), 1569737(4/28/2027), 1581652(7/28/2027); MQ1213/00801741097126/1558191(2/28/2027), 1559313(2/28/2027)
Quantity recalled71,498

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0467-2025
FDA event ID
95491
Recalling firm
Bard Peripheral Vascular, Tempe, AZ
Classification
Class II
Status
Ongoing
Recall initiated
30 Sep 2024
FDA classified
15 Nov 2024
Reported
27 Nov 2024
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

30 Sep 2024Recall initiated by company
15 Nov 2024Classified by FDA+46 days
27 Nov 2024Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Disposable biopsy instruments were potentially manufactured missing the backend notch retention feature on the needle that results in inadequate securing of the needle inside the device, which could lead to needle detachment and misplacement, which could lead to tissue damage and bleeding.

Product as listed by the FDA

Bard Marquee Disposable Core Biopsy Instrument Kit: BARD MARQUEE KIT 12G X 10 CM, REF: MQK1210; BARD MARQUEE 12G X 10 CM, REF: MQ1210; BARD MARQUEE Kit 12G X 13 CM, REF: MQK1213; BARD MARQUEE 12G X 13 CM, REF: MQ1213

Where it was distributed

Worldwide - US Nationwide including in the states of WA, LA, MN, PA, UT, SC, OK, KY, AZ, IL, TX, NJ, NY, FL, TN, IN, OH, NC, CO, VA, GA, MD, CA, AL, WI, MO, IA, CT, NE, MI, MS, NV, KS, OR, SD, ID, NH, RI, WY, AR, MA, DE, ND, NM, AK, PR and the countries of Portugal, Spain, South Africa, Greece, United Arab Emirates, United Kingdom, Sweden, Finland, Belgium, Korea, Australia, Canada.

Nationwide AlaskaAlabamaArkansasArizonaCaliforniaColoradoConnecticutDelawareFloridaGeorgiaIowaIdahoIllinoisIndianaKansasKentuckyLouisianaMassachusettsMarylandMichigan

Questions about this recall

Why was it recalled?

Disposable biopsy instruments were potentially manufactured missing the backend notch retention feature on the needle that results in inadequate securing of the needle inside the device, which could lead to needle detachment and misplacement, which could lead to tissue damage and bleeding.

Which lots are affected?

REF/UDI-DI/Lot(Expiration): MQK1210/00801741097263/1490758(9/28/2025), 1506044(1/28/2026), 1506045(1/28/2026), 1511827(2/28/2026), 1514692(3/28/2026), 1518977(4/28/2026), 1518978(4/28/2026), 1518979(4/28/2026), 1519143(4/28/2026), 1520507(5/28/2026), 1520508(5/28/2026), 1522157(5/28/2026), 1522158(5/28/2026), 1522577(5/28/2026), 1523785(6/28/2026), 1523914(6/28/2026), 1523915(6/28/2026), 1525370(6/28/2026), 1525371(6/28/2026), 1525373(6/28/2026), 1528417(7/28/2026), 1528418(7/28/2026), 1528495(7/28/2026), 1528496(7/28/2026), 1528497(7/28/2026), 1528560(7/28/2026), 0001618867(3/28/2028), 0001620281(3/28/2028), 0001632675(6/28/2028); MQ1210/00801741097119/1514460(3/28/2026), 1514461(3/28/2026), 1519144(4/28/2026), 1519145(4/28/2026), 1519456(4/28/2026), 1520066(5/28/2026), 1520067(5/28/2026), 1520506(5/28/2026), 1523783(6/28/2026), 1523784(6/28/2026), 0001618258(3/28/2028), 0001631611(6/28/2028), 0001633216(7/28/2028); MQK1213/00801741097270/1543517(10/28/2026), 1559312(2/28/2027), 1562724(3/28/2027), 1569737(4/28/2027), 1581652(7/28/2027); MQ1213/00801741097126/1558191(2/28/2027), 1559313(2/28/2027)

Where was it sold?

Worldwide - US Nationwide including in the states of WA, LA, MN, PA, UT, SC, OK, KY, AZ, IL, TX, NJ, NY, FL, TN, IN, OH, NC, CO, VA, GA, MD, CA, AL, WI, MO, IA, CT, NE, MI, MS, NV, KS, OR, SD, ID, NH, RI, WY, AR, MA, DE, ND, NM, AK, PR and the countries of Portugal, Spain, South Africa, Greece, United Arab Emirates, United Kingdom, Sweden, Finland, Belgium, Korea, Australia, Canada.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bard Peripheral Vascular

All 138

Other Other Medical Devices recalls

All 13,778